Skip to main content
Caplight Logo









ATDev

ATDev

Private
Orange, CaliforniaHealthcare & Life Scienceshttps://assistivetech.dev/

Last Round

Grant

Nov 6, 2025

Total Funding Raised

$3.61M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

ATDev is a health tech company that develops robotic mobility devices and a telehealth platform designed to assist with physical therapy and orthopedic rehabilitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Infrastructure

Keywords

robotic rehabilitationmedical roboticsassistive technologyrehab techphysical therapy hardwaretelehealthremote patient monitoringshared autonomyrobotics operating systemsimulation platformcomputer visionmedtechhealth IoTmedical deviceSaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ATDev Comparables

Compare ATDev with similar companies based on industry and business-model similarity.

ATDev comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
H ROBOTICS INC
86%
MYOLYN, Inc.
79%
Motus Nova
78%

ATDev Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 6, 2025
GrantNov 22, 2024
AcceleratorMay 29, 2024
SeedDec 7, 2022
GrantSep 14, 2021

Key People

Founding team and executive leadership

Todd Roberts

CEO And Co-founder

Founding Team

ATDev Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 157% MoM.

  • Aug 1, 2026

    Grew 25% QoQ from 12 to 15 employees.

ATDev Filings

Explore SEC and related filing metadata, where available.

ATDev filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ATDev's valuation, stock price, and market status.

Is ATDev a public or private company?

ATDev is a private company.

What is the current stock price of ATDev?

ATDev is a private company with no public stock price. No recent secondary market data is available.

How much is ATDev worth (valuation)?

Valuation information for ATDev is not publicly available.

Can I buy ATDev stock?

ATDev shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ATDev's last funding round?

ATDev's most recent funding round was Seed on October 16, 2025.

Who are the main investors in ATDev?

Key investors in ATDev include National Institute of Biomedical Imaging and Bioengineering, U.S. Department of Health and Human Services, MedTech Innovator, Big Red Ventures.

Will ATDev IPO soon?

No public IPO plans have been announced for ATDev.

How can I track ATDev secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ATDev's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOrange, California
Employee Range16
Year Founded2020
Last FundingNov 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?